DHEA benefits: what the studies show
Reviewed 21 sourcesPublished by PepVault
What DHEA does in human trials, as of November 2026: aging, bone, mood, IVF, the approved vaginal insert, hormone levels, side effects and its legal status.

- Last reviewed
- Sources
- 21
- Questions
- 10
- Compounds
- 1
The short answer
DHEA is a hormone made by the adrenal glands that the body turns into testosterone and estrogens. Blood levels peak around age 20 and fall to about a fifth of that after 70. Topping it up for two years in older adults did not change muscle, strength, insulin or quality of life. Its one approved use is a vaginal insert for painful sex after menopause.
Evidence: Human evidence is moderate: a two-year randomized trial in older adults, Cochrane reviews and meta-analyses of mostly small, short trials in women, and an FDA label for the vaginal insert; no fracture or lifespan data in people.

What is DHEA?
DHEA (dehydroepiandrosterone, drug name prasterone) is a steroid hormone made mostly by the adrenal glands, the small glands on top of the kidneys. On its own it does little: it is a prohormone, a raw material that tissues convert into androstenedione, testosterone and estradiol118. In the blood it travels mostly as DHEA-S, its sulfated form, and DHEA-S is what a lab test measures.
The reason it is sold for aging is its curve. In 981 men and 481 women aged 11 to 89, DHEA-S peaked at 20 to 24 in men (an average of 3,470 ng/mL, or 347 µg/dL) and at 15 to 19 in women (2,470 ng/mL), then fell steadily: after 70 the averages were 670 ng/mL in men and 450 in women, about a fifth of the peak1. Following 97 men over about 13 years confirmed the fall within the same people over time: levels dropped in two of every three men2.

Does DHEA work for anti-aging?
The largest test says no. At the Mayo Clinic, 87 older men with low DHEA-S and low testosterone and 57 older women with low DHEA-S took DHEA, testosterone (men only) or a placebo for two years, double-blind3. The trial doses were 75 mg of DHEA a day for men and 50 mg for women4. DHEA-S rose by a median 3.4 µg/mL in men and 3.8 in women3.
Nothing that defines aging moved. DHEA changed no measure of body composition, and neither hormone changed peak oxygen uptake (VO2 peak, the standard fitness test), muscle strength or insulin sensitivity. Quality of life did not improve. The only gains were in bone: femoral neck density in men and wrist density in women3. A follow-up paper from the same trial found no improvement in insulin secretion, insulin action or after-meal glucose either5.
Earlier, smaller trials looked brighter: people felt better on 50 mg nightly in a 6-month crossover of 30 adults, with no change in insulin sensitivity or body fat6, and a year of 50 mg in 280 French adults aged 60 to 79 helped bone turnover and libido in women over 70, and skin, mainly in women7.
What did the human trials measure, outcome by outcome?
Each dose below is the one the trial used, told as that.
| Outcome | Trial | Who | Trial dose | Result |
|---|---|---|---|---|
| Strength, body composition, fitness | Randomized, placebo, 2 years34 | 144 older adults with low DHEA-S | 75 mg a day (men), 50 mg (women) | No change in any of them, nor in insulin sensitivity or quality of life |
| Strength in trained men | Randomized, placebo, 12 weeks9 | 40 men, average age 48 | 100 mg a day | Lean mass +0.8 kg, strength +6.8 kg; not different from placebo; testosterone not raised |
| Bone density | Pooled data, 4 trials, 12 months4 | 295 women, 290 men aged 55 or older | Mostly 50 mg a day | Women: spine +1.0%, trochanter +0.5%, hip held; men: no bone gain |
| Quality of life after menopause | Cochrane review, 20158 | 28 trials, 1,273 women | Varied | No improvement (SMD 0.16, not significant) |
| Sexual function after menopause | Cochrane review, 20158 | 5 trials, 261 women | Varied | Slightly better (SMD 0.31) |
| Libido, lipids, glucose, weight, bone | Meta-analysis, 201410 | 23 trials, 1,188 women | Oral or skin DHEA | No significant effect on any of them |
| Wellbeing, adrenal insufficiency | Meta-analysis, 200912 | 10 trials in women | Varied | Small gain (effect size 0.21), "perhaps trivial" |
| Depression in midlife | Randomized crossover, 200514 | 46 adults aged 45 to 65 | 90 then 450 mg a day, 6 weeks | Depression score halved in 23 on DHEA against 13 on placebo |
| Live birth in IVF | Cochrane review, 202415 | 9 trials, 1,433 women | Varied, before IVF | Little to no difference (odds ratio 1.30, not significant) |
| Painful sex after menopause | Phase 3, 12 weeks17 | 482 women | 6.5 mg vaginal insert nightly | Pain score down 1.42 from baseline, 0.36 more than placebo |
SMD, the standardized mean difference, puts trials that used different scales on one scale: 0.2 is small, 0.5 moderate. The pattern: DHEA by mouth reliably raises DHEA-S and, in women, testosterone; the effects people buy it for are small, limited to women, or absent.
Does DHEA help bone density?
A little, in women. Pooling four year-long trials, including the Mayo one, women on DHEA gained 1.0% at the spine and 0.5% at the trochanter (the bony point of the hip) and held their total hip, while men gained nothing4. A separate meta-analysis also found hip density up in women and not in men16. Another, of 23 trials in postmenopausal women, found no significant bone effect at all10. None of these trials measured fractures.
The likely reason it shows in women: in a postmenopausal woman, DHEA is a main source of the estrogen and testosterone she still makes, and the pooled trials saw estradiol rise more in women (8.7 pg/mL) than in men (4.8 pg/mL)4.
Does DHEA help mood or depression?
The clearest result is in women whose adrenal glands have failed, who make almost no DHEA. In a four-month crossover of 24 such women, 50 mg each morning brought DHEA and testosterone back into the normal range and improved wellbeing, depression and anxiety scores and sexual interest against placebo13. When ten trials like it were pooled, the gain shrank to small and "perhaps trivial", and the reviewers found the evidence too thin to support routine use12.
In depression that began in midlife, an NIH crossover trial gave 46 men and women DHEA for six weeks, 90 mg a day and then 450 mg: 23 people had their depression score cut by half or more on DHEA, against 13 on placebo14. That is one small, short trial at doses far above the supplement shelf. In women around and after menopause, pooled trials found no gain in quality of life8.
Does DHEA help IVF or poor ovarian response?
Not by much, says the latest Cochrane review. It pooled 28 randomized trials, most in women who respond poorly to IVF stimulation (poor responders, whose ovaries yield few eggs). For DHEA before IVF, the live birth or ongoing pregnancy odds ratio was 1.30, a result that includes no effect: where 12% of women had a baby without DHEA, 12% to 20% would with it15. Clinical pregnancy and miscarriage did not change either.
Testosterone did better in the same review: an odds ratio of 2.53 for live birth, moving an expected 10% to between 15% and 30%15. The certainty was moderate to very low, mostly because many trials were not blinded.
What is Intrarosa, the approved DHEA?
Intrarosa is prasterone, DHEA under its drug name, as a 6.5 mg vaginal insert used once a day at bedtime. The FDA approved it on November 16, 2016 for moderate to severe pain during sex caused by vaginal and vulvar atrophy after menopause1118. As of November 2026 it is the only FDA-approved prasterone product, and no DHEA tablet or capsule is an approved drug18.
It works locally. Vaginal cells convert it to estrogens and androgens, and in the label's blood study testosterone barely moved (a peak of 0.15 against 0.12 ng/mL on placebo) and estradiol rose slightly (5.0 against 3.3 pg/mL)11. The label's most common side effect is vaginal discharge, which the phase 3 report puts down to the insert melting17: 14.2% of 521 women in a year-long open trial, where 2.1% had an abnormal Pap smear11. Because estrogen is one of its products, the label flags it for women with a history of breast cancer, in whom it has not been studied11.
When to get help Any vaginal bleeding after menopause, on DHEA or not, is a reason to see your clinician; the Intrarosa label asks for it to be checked before treatment starts11.
What does DHEA do to hormone levels, and what are the side effects?
In women, oral DHEA is a testosterone source. At 50 mg a night, androstenedione, testosterone and DHT (dihydrotestosterone) doubled in women, while men saw only a small rise in androstenedione6. In menopausal women that shows up as androgenic side effects, mainly acne, which were nearly four times as likely as on placebo (odds ratio 3.77)8. HDL cholesterol, the protective kind, dipped slightly in women in two trials613.
In the two-year Mayo trial there were no major adverse effects3, and a year of 50 mg in 280 older adults showed no harmful build-up of DHEA-S or active steroids7. In two of the four year-long trials pooled later, more heart and blood-vessel events were reported on DHEA than placebo; the events were classed differently from trial to trial and could not be pooled4.
Commonly reported: little that is felt day to day; oily skin and acne, and in some women more facial or body hair, the androgen effects the Cochrane reviewers name, acne and unwanted hair growth8.
Is DHEA legal, and is it banned in sport?
In the US it is sold over the counter as a dietary supplement, as of November 2026. The Anabolic Steroid Control Act of 2004 (signed October 22, 2004) rewrote the federal definition of an anabolic steroid, and the definition names DHEA among the hormones it excludes, so DHEA is not a controlled substance1920. Supplements are not approved by the FDA before sale, so a capsule's content is the maker's claim.
In sport it is banned at all times. The World Anti-Doping Agency's 2026 Prohibited List names prasterone (DHEA) under S1.1, anabolic androgenic steroids, in and out of competition21. For a tested athlete, any DHEA product risks a positive test. Our legal-status page for DHEA lists each check with its date.
Should I take DHEA?
Match the reason to the trial: for aging, strength or wellbeing, two years found nothing3; for bone in older women, a small gain4. DHEA is a hormone, and it adds to the same pool as testosterone, estrogen or any hormone therapy you are on. Whether it fits you is your prescriber's decision, ideally after a DHEA-S level shows whether yours is low.
DHEA is in PepVault's library. Add it to a protocol as an oral supplement and the app logs each day's capsule and can remind you at the time you set, so your prescriber sees exactly when you started. Log it in PepVault
Sources
- Orentreich N et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984. PubMed 6235241
- Orentreich N et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 1992. PubMed 1400863
- Nair KS et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006. PubMed 17050889
- Jankowski CM et al. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: a pooled analysis of four clinical trials. Clin Endocrinol (Oxf). 2019. PubMed 30421439
- Basu R et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes. 2007. PubMed 17327446
- Morales AJ et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994. PubMed 7515387
- Baulieu EE et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000. PubMed 10760294
- Scheffers CS et al. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015. PubMed 25879093
- Wallace MB et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999. PubMed 10613429
- Elraiyah T et al. The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014. PubMed 25279571
- Intrarosa (prasterone) vaginal insert, prescribing information. Millicent U.S. DailyMed, SPL version 9, August 2026. dailymed.nlm.nih.gov
- Alkatib AA et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab. 2009. PubMed 19773400
- Arlt W et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999. PubMed 10502590
- Schmidt PJ et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005. PubMed 15699292
- Naik S et al. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2024. PubMed 38837771
- Lin H et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults. Gynecol Endocrinol. 2019. PubMed 31237150
- Labrie F et al. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause. 2016. PubMed 26731686
- Drugs@FDA: NDA 208470, Intrarosa (prasterone), approved November 16, 2016. U.S. Food and Drug Administration. accessdata.fda.gov
- Public Law 108-358, the Anabolic Steroid Control Act of 2004 (October 22, 2004). U.S. Government Publishing Office. govinfo.gov
- 21 U.S.C. 802(41)(A), the definition of anabolic steroid (United States Code, 2023 edition). U.S. Government Publishing Office. govinfo.gov
- World Anti-Doping Agency. Prohibited List 2026, in effect from January 1, 2026: S1.1 anabolic androgenic steroids. wada-ama.org
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.